New Medtronic Data Demonstrate Clinical and Quality of Life Benefits for VenaSeal Closure System in Venous Reflux Disease Patients

World News: . []

Three-Year VeClose Trial and One-Year WAVES Study Data Presented at Charing Cross DUBLIN and LONDON - April 25 2017 - Medtronic plc NYSE MDT today announced three-year outcomes from the VeClose US pivotal clinical trial an d one-y...

More news and information about Medtronic plc

Published By:

Thomson Reuters: 16:30 GMT Tuesday 25th April 2017

Published: .

Search for other references to "medtronic" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us